These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 10349988)
21. Squamous cell carcinoma of the thyroid: an aggressive tumor associated with tall cell variant of papillary thyroid carcinoma. Kleer CG; Giordano TJ; Merino MJ Mod Pathol; 2000 Jul; 13(7):742-6. PubMed ID: 10912933 [TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical markers of tumor prognosis in breast cancer in Egypt. Helal T; Nassiri M; Khalifa A Cancer Detect Prev; 1997; 21(3):201-6. PubMed ID: 9167036 [TBL] [Abstract][Full Text] [Related]
23. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53. Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265 [TBL] [Abstract][Full Text] [Related]
24. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study. Samaratunga H; Khoo K Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444 [TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer. Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315 [TBL] [Abstract][Full Text] [Related]
26. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion]. Zhao WH; Xu BH; Zhang P; Li Q; Zhao LM; Sun Y Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):137-40. PubMed ID: 17645853 [TBL] [Abstract][Full Text] [Related]
27. Myxopapillary ependymomas: a clinicopathologic study of 14 cases including MIB-1 and p53 immunoreactivity. Prayson RA Mod Pathol; 1997 Apr; 10(4):304-10. PubMed ID: 9110291 [TBL] [Abstract][Full Text] [Related]
28. Concurrent overexpression of p53 and c-erbB-2 correlates with accelerated cycling and concomitant poor prognosis in node-negative breast cancer. Rudolph P; Alm P; Olsson H; Heidebrecht HJ; Fernö M; Baldetorp B; Parwaresch R Hum Pathol; 2001 Mar; 32(3):311-9. PubMed ID: 11274641 [TBL] [Abstract][Full Text] [Related]
29. [Comparative study of P 53, Bcl-2, and C-erbB-2 expression in low-grade papillary bladder tumors]. Ramos Soler D; Navarro Fos S; Villamón Fort R; Gil Salom M; Llombart Bosch A Arch Esp Urol; 2003 Apr; 56(3):277-85. PubMed ID: 12768988 [TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical co-expression of c-erbb-2/Neu oncoprotein, altered tumour suppressor (p53) protein, EGF-R and EMA in histological subtypes of infiltrating duct carcinoma of the breast. Sharma BK; Ray A; Kaur S; Gupta S Indian J Exp Biol; 1999 Mar; 37(3):223-7. PubMed ID: 10641149 [TBL] [Abstract][Full Text] [Related]
31. Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases. Jaehne M; Roeser K; Jaekel T; Schepers JD; Albert N; Löning T Cancer; 2005 Jun; 103(12):2526-33. PubMed ID: 15900577 [TBL] [Abstract][Full Text] [Related]
32. Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy. Turner BC; Gumbs AA; Carbone CJ; Carter D; Glazer PM; Haffty BG Cancer; 2000 Mar; 88(5):1091-8. PubMed ID: 10699900 [TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective study. Ma BB; Poon TC; To KF; Zee B; Mo FK; Chan CM; Ho S; Teo PM; Johnson PJ; Chan AT Head Neck; 2003 Oct; 25(10):864-72. PubMed ID: 12966511 [TBL] [Abstract][Full Text] [Related]
34. HER-2/neu and p53 overexpression as biomarkers of breast carcinoma in women age 30 years and younger. Maru D; Middleton LP; Wang S; Valero V; Sahin A Cancer; 2005 Mar; 103(5):900-5. PubMed ID: 15643600 [TBL] [Abstract][Full Text] [Related]
35. Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer. Yamashita H; Nishio M; Toyama T; Sugiura H; Zhang Z; Kobayashi S; Iwase H Breast Cancer Res; 2004; 6(1):R24-30. PubMed ID: 14680497 [TBL] [Abstract][Full Text] [Related]
36. Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma. González LO; Corte MD; Junquera S; González-Fernández R; del Casar JM; García C; Andicoechea A; Vázquez J; Pérez-Fernández R; Vizoso FJ Hum Pathol; 2009 Sep; 40(9):1224-33. PubMed ID: 19439346 [TBL] [Abstract][Full Text] [Related]
37. Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters. Seitz S; Poppe K; Fischer J; Nothnagel A; Estévez-Schwarz L; Haensch W; Schlag PM; Scherneck S J Pathol; 2001 Jul; 194(3):318-26. PubMed ID: 11439364 [TBL] [Abstract][Full Text] [Related]
38. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma. Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146 [TBL] [Abstract][Full Text] [Related]
39. Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases. Al-Ghamdi A; Freedman D; Miller D; Poh C; Rosin M; Zhang L; Gilks CB Gynecol Oncol; 2002 Jan; 84(1):94-101. PubMed ID: 11748983 [TBL] [Abstract][Full Text] [Related]
40. Breast carcinoma with micropapillary features: clinicopathologic study and long-term follow-up of 100 cases. Chen L; Fan Y; Lang RG; Guo XJ; Sun YL; Cui LF; Liu FF; Wei J; Zhang XM; Fu L Int J Surg Pathol; 2008 Apr; 16(2):155-63. PubMed ID: 18417672 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]